@article {Berkol45, author = {Tonguc D. Berkol and Yasin H. Balcioglu and Simge S. Kirlioglu and Zengibar Ozarslan and Serkan Islam and Ilker Ozyildirim}, title = {Clinical characteristics of antidepressant use and related manic switch in bipolar disorder}, volume = {24}, number = {1}, pages = {45--52}, year = {2019}, doi = {10.17712/nsj.2019.1.20180008}, publisher = {Neurosciences Journal}, abstract = {Objectives: To examine the association between clinical and treatment characteristics and antidepressants (AD)-induced manic switch in bipolar disorder (BD).Methods: Total of 238 euthymic BD patients, who had been followed-up for at least 6 months at the outpatient clinic of Haseki Training and Research Hospital in istanbul, Turkey, were enrolled in this cross-sectional study in 2016. Semi-structured data form, the mood chart, and the mirror-designated assessment were applied to all subjects. The files of the patients were retrospectively reviewed and the patients using ADs were compared as AD-monotherapy (AD-m) and AD-combination (AD-c) groups, then divided into 2 subgroups according to the presence/absence of manic switch under AD treatment.Results: Fifty eight (47.15\%) patients out of 123 who received ADs at least once had experienced a manic switch under AD treatment. The rate of manic switch in AD-m patients was significantly higher than the AD-c group. Independent from being monotherapy or combined treatment, AD use longer than 12 months was negatively associated with the occurrence of manic switch.Conclusion: Our study suggests that the risk of manic switch is especially prominent in the first months of AD use. Antidepressants use in combining it with a mood stabilizers (MS) may not be adequate in preventing switches in shorter terms. However, in longer term uses addition of MS to ADs may decrease the risk of switches.}, URL = {https://nsj.org.sa/content/24/1/45}, eprint = {https://nsj.org.sa/content/24/1/45.full.pdf}, journal = {Neurosciences Journal} }